Accufy Diagnostics, Inc. — SEC Form D Filing

Accufy Diagnostics, Inc. filed an SEC Form D on October 28, 2026, reporting $2.00M raised in Biotechnology.

Form D filing details

Filing
SEC Form D
Filing date
October 28, 2026
Amount reported
$2.00M
Round stage
Seed, as raising $2,000,000 through an equity offering typically corresponds to early-stage diagnostic development and platform validation.
Industry
Biotechnology
Website
https://accufydiagnostics.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Clinical laboratories and healthcare providers face delays and inaccuracies when using traditional diagnostic assays to identify complex biological markers.

Solution

Accufy Diagnostics develops high-sensitivity biotechnology diagnostic assays and platforms to streamline accurate disease detection.

Why now

Advancements in molecular biology and rapid microfluidic technology now allow diagnostic tools to achieve higher precision at significantly lower costs.

Source: SEC EDGAR Form D filing